A year after the stock market crash, these are the FTSE 100’s 6 biggest losers!

Since crashing to a low in March 2020, the FTSE 100 has soared by 35%. But these six sick stocks have dived over the past year!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

By any measure, 2020 was a tough year for investors. After a gentle start, all hell broke loose as Covid-19 waves washed over the world. This sent the FTSE 100 index plunging at the fastest rate I can recall since its creation in 1984.

The FTSE 100’s March meltdown

At the end of 2019, the FTSE 100 closed at 7,542.4 points. It then gently climbed, peaking at 7,674.6 on 17 January. Alas, this 1.8% rise gave no hint of the perfect storm to come. As Covid-19 spread globally, stock markets assumed the crash position. With investors all rushing to sell risky assets, share prices collapsed.

By 23 March 2020 (‘Meltdown Monday’), the FTSE 100 had lost 2,680 points since its 2020 peak to close at 4,993.90. Thus, the UK’s main market index had collapsed by more than a third (34.9%) in under 10 weeks. That’s among the steepest and most brutal market crashes I’ve seen in 35 years of investing. But, as billionaire investor Warren Buffett remarked, “Be fearful when others are greedy and greedy when others are fearful”.

Buying in March 2020 was a great move

In late March 2020, as the world was swamped with fear, I decided to be greedy. One reliable investment rule I’ve absorbed is to buy big when asset prices are low. Generally speaking, paying low prices for decent stocks is a winning strategy, especially with time on your side. A year ago, my wife and I pumped all of our cash into shares, mainly US and global stocks.

The bumper returns over the past year have been outstanding (enough to retire today, should we wish to). As for the FTSE 100, it stands at 6,734.71 points today. That’s a healthy gain of over 1,740 points since Meltdown Monday. This equates to a rebound of more than a third (34.9%) in just over 12 months. Nice.

Not all FTSE 100 shares bounced back

Of course, not all FTSE 100 shares have gained in value, like these five big winners. In fact, over the past year, nine of the Footsie’s 101 shares have actually fallen in value. For the record, these are the FTSE 100’s six biggest fallers in the year to today:

BAE Systems (aerospace engineering) -8.1%
National Grid (electricity & gas utility) -8.7%
BP (oil & gas) -10.2%
GlaxoSmithKline (pharmaceuticals) -13.6%
HSBC Holdings (global bank) -15.1%
Rolls-Royce Holdings (aero-engine maker) -23.6%

I like two of these losers

The first theme among these losers is air travel. BAE Systems and Rolls-Royce have been walloped by the collapse in airmiles flown. With international air travel not expected to return to normal before 2024, it could be tough going for FTSE 100 stalwarts BAE and RR.

The second theme among these laggards is energy. As oil prices collapsed, former FTSE 100 heavyweight BP took a beating in 2020, before bouncing back since November. Likewise, National Grid shares have suffered due to reduced energy usage. Of the two remaining losers, HSBC has suffered due to its status as one of the world’s leading lenders. And GSK has suffered a hit to earnings as routine vaccinations were cancelled during the Covid-19 crisis.

As a committed value investor, I try to find tomorrow’s winners from today’s losers. Hence, I love rooting around in the FTSE 100’s bargain bin, looking for beaten-down shares in solid businesses. Of the above six losers, I most like the look of HSBC and GSK. Any strong economic recovery post-Covid-19 would benefit these two stocks, so they are both on my watchlist.

Cliffdarcy owns shares in GlaxoSmithKline. The Motley Fool UK has recommended GlaxoSmithKline and HSBC Holdings. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »